The combination drug valsartan/sacubitril known as LCZ696 significantly reduced aortic systolic blood pressure and pulse pressure compared to the standard angiotensin receptor blocker (ARB) olmesartan in patients with hypertension.
http://www.sciencedaily.com/releases/2015/08/150831085508.htm
Lcz696 targets blood pressure and arterial stiffness
31 agosto 2015
Volver